Cranford Hospice is Hawke's Bay's leading palliative care provider. Our dedicated team is available 24 hours a day, seven days a week.
---------------------------
AXA
axaglobalhealthcare.com
Go further with international health insurance. Global support for people who think a little bigger
---------------------------
APOLLONIO
apollonion.com
The Apollonion Private Hospital is an ultra-modern Hospital purposely built to offer the best medical care to its patients.
---------------------------
Durbin
durbinglobal.com
Specialist medical suppliers in sourcing and distributing pharmaceuticals, medical equipment and consumable supplies.
---------------------------
Self
self.com
Women Magazine on Fitness, Health, Food, Beauty & more.
---------------------------
Easyway
allencarr.com
Allen Carr Easyway International operates clinics in more than 150 cities in over 50 countries worldwide.
---------------------------
id Hospital
idhospital.com
All kinds of plastic surgeries at affordable cost.
---------------------------
Al Zahra Hospital
alzahra.com
Al Zahra Hospital Sharjah is the first and the largest private general hospital in the UAE with both inpatient and outpatient treatment at an international standard,
---------------------------
Kunming Children�s Hospital
crhealthcare.com.hk
Kunming Children Hospital integrates first aid, medical treatment, rehabilitation, health care, & scientific research.
---------------------------
UT Health
uthealtheasttexas.com
UT Health East Texas is passionate about delivering the highest quality care with unmatched compassion, outstanding service and innovative technology.
---------------------------
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115277.jpg"/> (MedPage Today) -- Delgocitinib cream had superior efficacy and a better safety profile compared with oral alitretinoin for the treatment of severe chronic hand eczema, the randomized phase III DELTA FORCE trial showed.
Among over 500 patients...
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115250.jpg"/> (MedPage Today) -- Rheumatoid arthritis (RA) patients in Denmark with a history of solid tumor cancers, now in remission, faced no greater likelihood of cancer relapse when they were treated with biologic agents, compared with conventional disease...
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115194.jpg"/> (MedPage Today) -- The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new targeted drug for the inflammatory skin disease in over a decade, drugmakers Regeneron and Sanofi announced...
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115187.jpg"/> (MedPage Today) -- Adding narrowband ultraviolet B (UVB) phototherapy to oral treatment with ritlecitinib (Litfulo) enhanced repigmentation in patients with nonsegmental vitiligo compared with the drug alone, exploratory analysis of a phase IIb...
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115153.jpg"/> (MedPage Today) -- Droplet digital PCR measurements of circulating tumor (ct)DNA to assess minimal residual disease before the initiation of adjuvant therapy and during follow-up for patients with resected stage III melanoma may accurately identify...
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115125.jpg"/> (MedPage Today) -- On April 11, 2025, President Donald J. Trump underwent his annual physical examination at Walter Reed National Military Medical Center. I performed and supervised the comprehensive exam, which included diagnostic and laboratory...
<img src="https://clf1.medpagetoday.com/media/images/115xxx/115005.jpg"/> (MedPage Today) -- Note that some links may require registration or subscription. MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts. If you want to share your story, please email MPT_Editorial...
<img src="https://clf1.medpagetoday.com/media/images/114xxx/114768.jpg"/> (MedPage Today) -- Biologics targeting interleukin (IL)-12, IL-23, and IL-17 were associated with a lower rate of serious infections among older adults with psoriatic disease, a Canadian cohort study showed.
For more than 11,000 older adults started...
<img src="https://clf1.medpagetoday.com/media/images/114xxx/114730.jpg"/> (MedPage Today) -- The latest trend in treating hair loss may sound familiar -- essentially, it's a repurposed drug first popularized in the 1990s.
Back then, TV viewers were inundated with ads for Rogaine, a sticky topical solution that could...
<img src="https://clf1.medpagetoday.com/media/images/114xxx/114717.jpg"/> (MedPage Today) -- The runaway costs of skin substitutes for treating chronic wounds have experts and accountable care organizations (ACOs) sounding the alarm, and new rules targeting profiteering in the industry are now in limbo under the Trump...
<img src="https://clf1.medpagetoday.com/media/images/114xxx/114702.jpg"/> (MedPage Today) -- A preprint study suggested that GLP-1 receptor agonists may be associated with hair loss, though only in women.
Using a random sample of 16 million patients, researchers found that women who newly initiated semaglutide (Ozempic...
<img src="https://clf1.medpagetoday.com/media/images/114xxx/114693.jpg"/> (MedPage Today) -- With spironolactone (Aldactone) treatment for acne rising several-fold in recent decades, safety concerns persist for this off-label practice in understudied populations.
A database of U.S. insurance claims showed that among...
<img src="https://clf1.medpagetoday.com/media/images/114xxx/114650.jpg"/> (MedPage Today) -- Note that some links may require registration or subscription.
MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts. If you want to share your story, please email MPT_Editorial...
<img src="https://clf1.medpagetoday.com/media/images/114xxx/114634.jpg"/> (MedPage Today) -- ORLANDO -- More than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 weeks of treatment with an investigational dual-target small-molecule inhibitor, according to a study...
<img src="https://clf1.medpagetoday.com/media/images/114xxx/114594.jpg"/> (MedPage Today) -- ORLANDO -- More than 40% of patients with longstanding prurigo nodularis (PN) had significant improvement within 3 months of starting topical ruxolitinib (Opzelura), according to a study reported here.
After 12 weeks of treatment...
<img src="https://clf1.medpagetoday.com/media/images/114xxx/114579.jpg"/> (MedPage Today) -- ORLANDO -- The TYK2 inhibitor deucravacitinib (Sotyktu) showed clinical potential in two diseases other than psoriasis, according to studies reported here.
More than half of patients with psoriatic arthritis (PsA) had at least...
<img src="https://clf1.medpagetoday.com/media/images/114xxx/114570.jpg"/> (MedPage Today) -- ORLANDO -- A novel therapy for atopic dermatitis (AD) led to at least 75% improvement in a third of patients after 6 months, a placebo-controlled trial showed.
Including patients who used topical rescue medication, almost...
<img src="https://clf1.medpagetoday.com/media/images/114xxx/114558.jpg"/> (MedPage Today) -- ORLANDO -- Two-thirds of patients with moderate or severe plaque psoriasis had complete or nearly complete clearance at 4 months with an oral peptide targeting interleukin (IL)-23, a randomized study showed.
The primary analysis...
<img src="https://clf1.medpagetoday.com/media/images/114xxx/114532.jpg"/> (MedPage Today) -- Two adalimumab biosimilars (Amjevita and Imraldi) worked as well for moderate to severe psoriasis as the original brand-name product (Humira) for patients either starting or switching treatment, according to real-world data from...
<img src="https://clf1.medpagetoday.com/media/images/114xxx/114498.jpg"/> (MedPage Today) -- SAN DIEGO -- Biologic treatment for atopic dermatitis appeared to improve growth trajectories for younger children, a trial analysis showed.
Over the course of 16 weeks of treatment in the pivotal randomized trials, children...
Home
Contact
Back to "Medical Updates - Homepage"
